FR2589732B1 - Nouvelle formulation a liberation prolongee a base de pindolol - Google Patents

Nouvelle formulation a liberation prolongee a base de pindolol

Info

Publication number
FR2589732B1
FR2589732B1 FR868613668A FR8613668A FR2589732B1 FR 2589732 B1 FR2589732 B1 FR 2589732B1 FR 868613668 A FR868613668 A FR 868613668A FR 8613668 A FR8613668 A FR 8613668A FR 2589732 B1 FR2589732 B1 FR 2589732B1
Authority
FR
France
Prior art keywords
pindolol
release formulation
extended release
formulation based
new extended
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR868613668A
Other languages
English (en)
French (fr)
Other versions
FR2589732A1 (fr
Inventor
Othmar Zuger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858524135A external-priority patent/GB8524135D0/en
Priority claimed from GB858524653A external-priority patent/GB8524653D0/en
Priority claimed from GB858531419A external-priority patent/GB8531419D0/en
Priority claimed from GB868603097A external-priority patent/GB8603097D0/en
Priority claimed from GB868605037A external-priority patent/GB8605037D0/en
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of FR2589732A1 publication Critical patent/FR2589732A1/fr
Application granted granted Critical
Publication of FR2589732B1 publication Critical patent/FR2589732B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FR868613668A 1985-10-01 1986-10-01 Nouvelle formulation a liberation prolongee a base de pindolol Expired FR2589732B1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB858524135A GB8524135D0 (en) 1985-10-01 1985-10-01 Darodipine compositions
GB858524653A GB8524653D0 (en) 1985-10-07 1985-10-07 Pharmaceutical formulations
GB858531419A GB8531419D0 (en) 1985-12-20 1985-12-20 Pindolol compositions
GB868603097A GB8603097D0 (en) 1986-02-07 1986-02-07 Pharmaceutical formulations
GB868605037A GB8605037D0 (en) 1986-02-28 1986-02-28 Oral pharmaceutical compositions

Publications (2)

Publication Number Publication Date
FR2589732A1 FR2589732A1 (fr) 1987-05-15
FR2589732B1 true FR2589732B1 (fr) 1989-07-13

Family

ID=27516617

Family Applications (1)

Application Number Title Priority Date Filing Date
FR868613668A Expired FR2589732B1 (fr) 1985-10-01 1986-10-01 Nouvelle formulation a liberation prolongee a base de pindolol

Country Status (20)

Country Link
KR (1) KR920008817B1 (enExample)
AT (1) AT402257B (enExample)
BE (1) BE905516A (enExample)
CA (1) CA1298784C (enExample)
CH (1) CH669524A5 (enExample)
DE (1) DE3632201C2 (enExample)
DK (1) DK170016B1 (enExample)
ES (1) ES2002508A6 (enExample)
FR (1) FR2589732B1 (enExample)
GR (1) GR862457B (enExample)
HK (1) HK392A (enExample)
HU (1) HU197201B (enExample)
IE (1) IE59589B1 (enExample)
IL (1) IL80182A (enExample)
LU (1) LU86615A1 (enExample)
NL (1) NL194822C (enExample)
NZ (1) NZ217732A (enExample)
PT (1) PT83456B (enExample)
SE (1) SE503222C2 (enExample)
SG (1) SG103391G (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440457B1 (en) 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
WO2003065970A2 (en) * 2001-02-20 2003-08-14 Royal College Of Surgeons Ie Treatment of fibromyalgia and related fatigue syndromes using pindolol
TW200616681A (en) * 2004-10-05 2006-06-01 Recordati Ireland Ltd Lercanidipine capsules

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
CH639659A5 (de) * 1978-12-18 1983-11-30 Sandoz Ag Neue 1,4-dihydropyridinderivate, deren herstellung und verwendung.
DD145004A3 (de) * 1978-09-25 1980-11-19 Reinhard Huettenrauch Verfahren zur herstellung fester a zneiformen
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
JPS6056122B2 (ja) * 1980-05-21 1985-12-09 塩野義製薬株式会社 徐放性製剤
GB2084017B (en) * 1980-09-18 1984-08-22 Sandoz Ltd Pharmaceutical compositions effective against coronary heat disease and hypertension
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
CA1208558A (en) * 1982-10-07 1986-07-29 Kazuo Kigasawa Soft buccal
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
JPS61501511A (ja) * 1984-03-21 1986-07-24 アメリカン・ホ−ム・プロダクツ・コ−ポレイション 徐放性医薬カプセル
JPS6124516A (ja) * 1984-07-12 1986-02-03 Fujisawa Pharmaceut Co Ltd 持続性錠剤

Also Published As

Publication number Publication date
AT402257B (de) 1997-03-25
HUT44701A (en) 1988-04-28
IL80182A0 (en) 1986-12-31
DE3632201A1 (de) 1987-04-02
DE3632201C2 (de) 1997-05-07
KR870003777A (ko) 1987-05-04
IL80182A (en) 1991-01-31
IE59589B1 (en) 1994-03-09
SG103391G (en) 1992-01-17
DK170016B1 (da) 1995-05-01
LU86615A1 (fr) 1987-04-02
GR862457B (en) 1987-01-29
CA1298784C (en) 1992-04-14
NL194822C (nl) 2003-04-03
DK464686D0 (da) 1986-09-29
SE8604112L (sv) 1987-04-02
ATA260486A (de) 1996-08-15
HU197201B (en) 1989-03-28
ES2002508A6 (es) 1988-08-16
IE862565L (en) 1987-04-01
NZ217732A (en) 1990-07-26
PT83456A (en) 1986-10-01
DK464686A (da) 1987-04-02
PT83456B (pt) 1989-05-12
SE8604112D0 (sv) 1986-09-29
NL194822B (nl) 2002-12-02
FR2589732A1 (fr) 1987-05-15
NL8602370A (nl) 1987-05-04
HK392A (en) 1992-01-10
KR920008817B1 (ko) 1992-10-09
SE503222C2 (sv) 1996-04-22
CH669524A5 (enExample) 1989-03-31
BE905516A (fr) 1987-03-30

Similar Documents

Publication Publication Date Title
IT8648450A0 (it) Composizione orale antitartaro
IT8648451A0 (it) Composizione orale antitartaro
BE865150A (fr) Base d'ancrage
BR8907584A (pt) Composicao de revestimento a base de fluorpolimero
IT8620877A0 (it) Composizione a base di benzina.
IT8521654A0 (it) Formulazioni topiche a lento rilascio.
BR9002396A (pt) Composicao estabilizada a base de 3-isotiazolonas
KR870700539A (ko) 앵커
FR2580495B1 (fr) Preparation dentaire a base d'emulsanne
ES2025120B3 (es) Dispositivo para decorar objetos
ATA225988A (de) Selbstfaerbestempel
DK165034C (da) Markeringsindretning
KR890015333A (ko) 칼라 수상관
FR2638755B1 (fr) Compositions durcissables a base de silicone
IT1213320B (it) Composizione farmaceutica orale a base di ubichinoni.
FI894181A7 (fi) Etaanisulfonamidijohdannaisia
PT92682A (pt) Processo para a preparacao de uma composicao a base de trimebutina de libertacao prolongada
FR2521997B1 (fr) Nouvelle association medicamenteuse a base de morniflumate
ES552148A0 (es) Procedimiento para preparar composiciones fungicidas a base de anilazinas
IT8647748A0 (it) Composizione orale antitartaro
FR2583042B1 (fr) Compositions analgesiques a base de (alkoxy-alkyl-hydroxy-phenyl) cyclohexanol
FR2586248B1 (fr) Insecticide a base de trihalogeno-imidazole
IT7805210A0 (it) Base di sostegno a piu' raggi per poltrone
KR860012715U (ko) 부착식 향분 발생지
KR880004605U (ko) 받침구가 부착된 비누

Legal Events

Date Code Title Description
CC Supplementary protection certificate (spc) laid open to the public (law of 25 june 1990)

Free format text: 92C0174, 920507

CB Supplementary protection certificate (spc) granted (law of 25 june 1990)

Free format text: 92C0167, 861001

CL Concession to grant licences
TP Transmission of property